Sign up to save your podcasts
Or
Share Variation in Endpoints for FDA Approved Migraine Therapies
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Variation in Endpoints for FDA Approved Migraine Therapies
Dr. Leigh Sharpless discusses her paper, "Variation in Endpoints in FDA Medication Approvals: A Review of Acute and Preventive Migraine Medications".
Show References: https://n.neurology.org/content/101/10/e989
https://directory.libsyn.com/episode/index/id/27962343
View all episodes
By American Academy of Neurology
4.8
129129 ratings
Dr. Leigh Sharpless discusses her paper, "Variation in Endpoints in FDA Medication Approvals: A Review of Acute and Preventive Migraine Medications".
Show References: https://n.neurology.org/content/101/10/e989
https://directory.libsyn.com/episode/index/id/27962343
More shows like Neurology Minute
View all
JAMA Editors' Summary
129 Listeners
Neurology® Podcast
280 Listeners
NEJM This Week
316 Listeners
Practical Neurology Podcast
34 Listeners
JAMA Clinical Reviews
481 Listeners
JAMA Neurology Author Interviews
14 Listeners
JAMA Medical News
90 Listeners
Neurology Today in 5
21 Listeners
Annals On Call Podcast
179 Listeners
Navigating Neuropsychology
341 Listeners
The Clinical Problem Solvers
509 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
320 Listeners
Neurology Exam Prep Podcast
180 Listeners
The Curious Clinicians
362 Listeners
Continuum Audio
73 Listeners